Kenichi Tanaka to In Vitro Techniques
This is a "connection" page, showing publications Kenichi Tanaka has written about In Vitro Techniques.
Connection Strength
0.471
-
In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma. J Cardiothorac Vasc Anesth. 2010 Jun; 24(3):408-12.
Score: 0.082
-
Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma. Anesth Analg. 2008 Mar; 106(3):719-24, table of contents.
Score: 0.073
-
Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. Anesth Analg. 2007 Oct; 105(4):933-9, table of contents.
Score: 0.071
-
A novel method to assess platelet inhibition by eptifibatide with thrombelastograph. Anesth Analg. 2004 Dec; 99(6):1794-1799.
Score: 0.059
-
The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth Analg. 2004 Nov; 99(5):1283-1289.
Score: 0.058
-
Electron microscopic evaluations of clot morphology during thrombelastography. Anesth Analg. 2004 Nov; 99(5):1440-1444.
Score: 0.058
-
Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. Thromb Res. 2004; 113(5):333-9.
Score: 0.055
-
The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery. Anesth Analg. 2003 Feb; 96(2):539-44, table of contents.
Score: 0.013